Literature DB >> 31667539

From molecules to system failure: translational frontiers of multimodal imaging in neurodegenerative diseases.

Thilo van Eimeren1,2,3, Alexander Drzezga4,5,6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31667539     DOI： 10.1007/s00259-019-04562-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  17 in total

Review 1.  Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.

Authors:  J Q Trojanowski; V M Lee
Journal:  Arch Neurol       Date:  1998-02

Review 2.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

3.  In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.

Authors:  Julian Dronse; Klaus Fliessbach; Gérard N Bischof; Boris von Reutern; Jennifer Faber; Jochen Hammes; Georg Kuhnert; Bernd Neumaier; Oezguer A Onur; Juraj Kukolja; Thilo van Eimeren; Frank Jessen; Gereon R Fink; Thomas Klockgether; Alexander Drzezga
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Authors:  Dietmar R Thal; Udo Rüb; Mario Orantes; Heiko Braak
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

Review 5.  Complex brain networks: graph theoretical analysis of structural and functional systems.

Authors:  Ed Bullmore; Olaf Sporns
Journal:  Nat Rev Neurosci       Date:  2009-02-04       Impact factor: 34.870

Review 6.  The amyloid state of proteins in human diseases.

Authors:  David Eisenberg; Mathias Jucker
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

7.  Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease.

Authors:  Dag Sehlin; Xiaotian T Fang; Linda Cato; Gunnar Antoni; Lars Lannfelt; Stina Syvänen
Journal:  Nat Commun       Date:  2016-02-19       Impact factor: 14.919

Review 8.  Engineered antibodies: new possibilities for brain PET?

Authors:  Dag Sehlin; Stina Syvänen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-24       Impact factor: 9.236

Review 9.  Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer's disease.

Authors:  Delphine Boche; Alexander Gerhard; Elena Rodriguez-Vieitez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-08       Impact factor: 9.236

10.  Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.

Authors:  Michel J Grothe; Jorge Sepulcre; Gabriel Gonzalez-Escamilla; Irina Jelistratova; Michael Schöll; Oskar Hansson; Stefan J Teipel
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.